ClinicalTrials.gov
ClinicalTrials.gov Menu

Zoledronic Acid (ZOMETA) With Cyclophosphamide With Neuroblastoma and Cortical Bone Involvement

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00206388
Recruitment Status : Completed
First Posted : September 21, 2005
Last Update Posted : August 2, 2013
Sponsor:
Collaborator:
New Approaches to Neuroblastoma Therapy Consortium
Information provided by (Responsible Party):
Peter Zage, Baylor College of Medicine

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2008
  Actual Study Completion Date : May 2013